These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7327 related items for PubMed ID: 2957032

  • 21. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
    Vassal G, Boland I, Terrier-Lacombe MJ, Watson AJ, Margison GP, Vénuat AM, Morizet J, Parker F, Lacroix C, Lellouch-Tubiana A, Pierre-Kahn A, Poullain MG, Gouyette A.
    Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
    [Abstract] [Full Text] [Related]

  • 22. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T, Suzumura Y, Fukushima M, Honda T, Nakanishi T, Noguchi T.
    Anticancer Res; 1988 Feb; 8(4):573-9. PubMed ID: 3178149
    [Abstract] [Full Text] [Related]

  • 23. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
    Demidem A, Morvan D, Papon J, De Latour M, Madelmont JC.
    Cancer Res; 2001 Mar 01; 61(5):2294-300. PubMed ID: 11280801
    [Abstract] [Full Text] [Related]

  • 24. Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments.
    Jeney A, Kopper L, Nagy P, Lapis K, Süli-Vargha H, Medzihradszky K.
    Cancer Chemother Pharmacol; 1986 Mar 01; 16(2):129-32. PubMed ID: 3948298
    [Abstract] [Full Text] [Related]

  • 25. Two glycine containing 2-chloroethylnitrosoureas--a comparative study on some physicochemical properties, in vivo antimelanomic effects and immunomodulatory properties.
    Zheleva A, Stanilova S, Dobreva Z, Zhelev Z.
    Int J Pharm; 2001 Jul 17; 222(2):237-42. PubMed ID: 11427354
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.
    Chern JW, Leu YL, Wang SS, Jou R, Lee CF, Tsou PC, Hsu SC, Liaw YC, Lin HM.
    J Med Chem; 1997 Jul 04; 40(14):2276-86. PubMed ID: 9216847
    [Abstract] [Full Text] [Related]

  • 27. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S, Ogawa M, Sakurai Y.
    Cancer Res; 1982 Oct 04; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract] [Full Text] [Related]

  • 28. A search for antitumor compounds. XI. Biologic studies. Antitumor properties of 19 new 9-aminoacridine and 1-or 3-nitro-9-aminoacridine derivatives.
    Hrabowska M, Ledóchowski A, Onoszko K.
    Arch Immunol Ther Exp (Warsz); 1976 Oct 04; 24(2):249-58. PubMed ID: 1275662
    [Abstract] [Full Text] [Related]

  • 29. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.
    Imbach JL, Montero JL, Moruzzi A, Serrou B, Chenu E, Hayat M, Mathe G.
    Biomedicine; 1975 Dec 20; 23(10):410-3. PubMed ID: 1222217
    [Abstract] [Full Text] [Related]

  • 30. Granulocyte colony-stimulating factor demonstrates antitumor activity in melanoma model in mice.
    Gołab J, Zagozdzon R, Stokłosa T, Kaca A, Dabrowska A, Giermasz A, Feleszko W, Jakóbisiak M.
    Neoplasma; 1998 Dec 20; 45(1):35-9. PubMed ID: 9605000
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Spin labelled nitrosoureas and triazenes and their non-labelled clinically used analogues--a comparative study on their physicochemical properties and antimelanomic effects.
    Zheleva AM, Gadjeva VG.
    Int J Pharm; 2001 Jan 16; 212(2):257-66. PubMed ID: 11165083
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and activities of antitumor agents.
    Suami T, Machinami T, Hisamatsu T.
    J Med Chem; 1979 Mar 16; 22(3):247-50. PubMed ID: 423206
    [Abstract] [Full Text] [Related]

  • 34. Synthesis of nitrosourea derivatives of sucrose as central nervous system anticancer agents.
    Almquist RG, Reist EJ.
    J Med Chem; 1977 Oct 16; 20(10):1246-50. PubMed ID: 903916
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (VI)].
    Miyahara M, Kamiya S, Nakadate M, Sueyoshi S, Tanno M, Miyahara M.
    Eisei Shikenjo Hokoku; 1982 Oct 16; (100):163-5. PubMed ID: 7183380
    [No Abstract] [Full Text] [Related]

  • 37. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
    Komatsu Y, Tomizaki KY, Tsukamoto M, Kato T, Nishino N, Sato S, Yamori T, Tsuruo T, Furumai R, Yoshida M, Horinouchi S, Hayashi H.
    Cancer Res; 2001 Jun 01; 61(11):4459-66. PubMed ID: 11389076
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Spin labeled amino acid nitrosourea derivatives--synthesis and antitumour activity.
    Zheleva A, Raikov Z, Ilarionova M, Todorov D.
    Pharmazie; 1995 Jan 01; 50(1):25-6. PubMed ID: 7886121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 367.